Cargando…

Behavioral activation therapy for depression and anxiety in cancer patients: a case series study

BACKGROUND: Behavioral activation therapy (BAT) directly addresses activities that individuals value most highly, and may be easily applicable to cancer patients. However, there is no established evidence of the use of BAT in this population. In this study, we examined the possibility of a BAT progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayama, Takatoshi, Ogawa, Yuko, Yanai, Yuko, Suzuki, Shin-ichi, Shimizu, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487522/
https://www.ncbi.nlm.nih.gov/pubmed/31168316
http://dx.doi.org/10.1186/s13030-019-0151-6
_version_ 1783414514844172288
author Hirayama, Takatoshi
Ogawa, Yuko
Yanai, Yuko
Suzuki, Shin-ichi
Shimizu, Ken
author_facet Hirayama, Takatoshi
Ogawa, Yuko
Yanai, Yuko
Suzuki, Shin-ichi
Shimizu, Ken
author_sort Hirayama, Takatoshi
collection PubMed
description BACKGROUND: Behavioral activation therapy (BAT) directly addresses activities that individuals value most highly, and may be easily applicable to cancer patients. However, there is no established evidence of the use of BAT in this population. In this study, we examined the possibility of a BAT program for depression and anxiety in cancer patients. CASE PRESENTATION: We retrospectively reviewed the medical records of cancer patients with each of the following characteristics: 1) were outpatients or inpatients visiting the psycho-oncology division of the National Cancer Center Hospital in Japan; 2) met criteria for Major Depressive Disorder or Adjustment Disorders; and 3) participated in a BAT program. The primary outcome was the program completion percentage. Secondary outcomes were self-reported depression severity (Patient Health Questionnaire-9 (PHQ-9) score), anxiety disorder status (Generalized Anxiety Disorder-7 (GAD-7) score), and clinical improvement (Clinical Global Impression-Improvement (CGI-I) score) after the program. We analyzed both depression and anxiety by the matched paired t-test. Ten patients participated in the program, and nine completed it. One dropped out due to cognitive impairment secondary to brain metastasis. Both the PHQ-9 scores (pre: 14.4 (SD, 6.1); post: 5.1 (SD, 5.8)) and the GAD-7 scores (pre: 11.9 (SD, 4.9); post: 4.7 (SD, 5.5)) significantly improved after the program (PHQ-9: P = 0.0014; GAD-7: P = 0.0004). CGI-I scores ranged from 1 to 3, and all subjects except the patient who dropped out improved clinically. Among the ten patients, three distinctive cases could be observed as follows. Case 1; a 45-year-old housewife with breast cancer who did not agree to take antidepressants because of concerns about the side effects achieved remission without antidepressants and began to live an active life. Case 4; a 66-year-old housewife was so shocked after endometrial cancer diagnosis that she was absent-minded and her compliance with the assigned homework was poor, therefore, her depression did not improve much. Case 9; a 62-year-old man with laryngeal cancer who had recurrent anxiety. Increased business activity, on which he put great value, gradually allowed him to be able to live his life actively without concerns. CONCLUSIONS: This study suggests that BAT would be effective for the depression and anxiety of cancer patients.
format Online
Article
Text
id pubmed-6487522
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64875222019-06-05 Behavioral activation therapy for depression and anxiety in cancer patients: a case series study Hirayama, Takatoshi Ogawa, Yuko Yanai, Yuko Suzuki, Shin-ichi Shimizu, Ken Biopsychosoc Med Case Report BACKGROUND: Behavioral activation therapy (BAT) directly addresses activities that individuals value most highly, and may be easily applicable to cancer patients. However, there is no established evidence of the use of BAT in this population. In this study, we examined the possibility of a BAT program for depression and anxiety in cancer patients. CASE PRESENTATION: We retrospectively reviewed the medical records of cancer patients with each of the following characteristics: 1) were outpatients or inpatients visiting the psycho-oncology division of the National Cancer Center Hospital in Japan; 2) met criteria for Major Depressive Disorder or Adjustment Disorders; and 3) participated in a BAT program. The primary outcome was the program completion percentage. Secondary outcomes were self-reported depression severity (Patient Health Questionnaire-9 (PHQ-9) score), anxiety disorder status (Generalized Anxiety Disorder-7 (GAD-7) score), and clinical improvement (Clinical Global Impression-Improvement (CGI-I) score) after the program. We analyzed both depression and anxiety by the matched paired t-test. Ten patients participated in the program, and nine completed it. One dropped out due to cognitive impairment secondary to brain metastasis. Both the PHQ-9 scores (pre: 14.4 (SD, 6.1); post: 5.1 (SD, 5.8)) and the GAD-7 scores (pre: 11.9 (SD, 4.9); post: 4.7 (SD, 5.5)) significantly improved after the program (PHQ-9: P = 0.0014; GAD-7: P = 0.0004). CGI-I scores ranged from 1 to 3, and all subjects except the patient who dropped out improved clinically. Among the ten patients, three distinctive cases could be observed as follows. Case 1; a 45-year-old housewife with breast cancer who did not agree to take antidepressants because of concerns about the side effects achieved remission without antidepressants and began to live an active life. Case 4; a 66-year-old housewife was so shocked after endometrial cancer diagnosis that she was absent-minded and her compliance with the assigned homework was poor, therefore, her depression did not improve much. Case 9; a 62-year-old man with laryngeal cancer who had recurrent anxiety. Increased business activity, on which he put great value, gradually allowed him to be able to live his life actively without concerns. CONCLUSIONS: This study suggests that BAT would be effective for the depression and anxiety of cancer patients. BioMed Central 2019-04-29 /pmc/articles/PMC6487522/ /pubmed/31168316 http://dx.doi.org/10.1186/s13030-019-0151-6 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Hirayama, Takatoshi
Ogawa, Yuko
Yanai, Yuko
Suzuki, Shin-ichi
Shimizu, Ken
Behavioral activation therapy for depression and anxiety in cancer patients: a case series study
title Behavioral activation therapy for depression and anxiety in cancer patients: a case series study
title_full Behavioral activation therapy for depression and anxiety in cancer patients: a case series study
title_fullStr Behavioral activation therapy for depression and anxiety in cancer patients: a case series study
title_full_unstemmed Behavioral activation therapy for depression and anxiety in cancer patients: a case series study
title_short Behavioral activation therapy for depression and anxiety in cancer patients: a case series study
title_sort behavioral activation therapy for depression and anxiety in cancer patients: a case series study
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487522/
https://www.ncbi.nlm.nih.gov/pubmed/31168316
http://dx.doi.org/10.1186/s13030-019-0151-6
work_keys_str_mv AT hirayamatakatoshi behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy
AT ogawayuko behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy
AT yanaiyuko behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy
AT suzukishinichi behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy
AT shimizuken behavioralactivationtherapyfordepressionandanxietyincancerpatientsacaseseriesstudy